封面
市場調查報告書
商品編碼
1577076

女性健康設備市場、機會、成長動力、產業趨勢分析與預測,2024-2032

Women Health Devices Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 199 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年全球女性健康器材市場價值約為1,299億美元,預計2024年至2032年複合年成長率為9.2%。狀況。這些設備滿足女性從青春期到更年期等各個生命階段的解剖和生理需求。它們涵蓋生殖健康、婦科護理以及乳癌、子宮頸癌、骨質疏鬆症和骨盆底疾病等疾病。全球人口老化,尤其是女性人口老化,導致尿失禁問題日益嚴重。這種情況通常是由於骨盆底肌肉衰弱造成的,影響著美國約 2500 萬成年人,其中 75-80% 是女性,全世界約有 2 億人受到這種情況的影響。

整個女性健康器械產業根據產品、應用、最終用戶和地區進行分類。

女性健康器械市場分為器械和消耗品。設備領域包括避孕設備、生育監測工具、經期保健產品、乳房及骨盆腔健康設備、孕產婦保健產品、一般健康監測儀、婦科醫療設備等。預測顯示,到2032 年,這一領域將達到2,114 億美元。 ,以及社會向預防性醫療保健的轉變。

市場分為癌症、骨質疏鬆、傳染病、子宮肌瘤、懷孕、女性絕育、月經失調等領域。在分析期間,傳染病細分市場的複合年成長率預計為 7.9%。影響女性的傳染病,如泌尿道感染 (UTI)、性傳染感染 (STI) 和陰道感染,在全球範圍內普遍流行。例如,世界衛生組織在 2022 年報告稱,有 2,000 萬名女性愛滋病毒呈陽性,新增病例 54 萬例,相關死亡人數為 2.3 萬人。

在美國,到 2032 年,女性健康設備市場預計將達到 788 億美元。促進定期篩檢和早期診斷(尤其是乳癌和骨質疏鬆症)的措施進一步推動了這一成長。其他成長動力包括醫療保健支出的增加、政府的支持性舉措、醫療技術的進步以及與生活方式相關的疾病的日益流行。這些因素共同提高了女性醫療保健的可近性和質量,從而擴大了市場。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業影響力
    • 成長動力
      • 已開發國家婦女的​​疾病負擔日益增加
      • 全球老年女性人口不斷增加
      • 醫療保健產業的技術進步
      • 提高發展中國家對婦女健康的認知
    • 產業陷阱與挑戰
      • 設備和程序成本高
      • 低度開發經濟體的婦女缺乏認知
  • 成長潛力分析
  • 技術景觀
  • 未來市場趨勢
  • 監管環境
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 介紹
  • 公司市佔率分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略展望矩陣

第 5 章:市場估計與預測:按產品分類,2021 - 2032 年

  • 主要趨勢
  • 裝置
    • 避孕器具
    • 生育力監測設備
    • 經期保健品
    • 乳房健康裝置
    • 骨盆健康設備
    • 孕產婦保健品
    • 一般健康監測設備
    • 用於婦科疾病的醫療器械
    • 其他設備
  • 耗材

第 6 章:市場估計與預測:按應用分類,2021 - 2032

  • 主要趨勢
  • 癌症
  • 骨質疏鬆症
  • 傳染病
  • 子宮肌瘤
  • 懷孕
  • 女性絕育
  • 月經失調
  • 其他應用

第 7 章:市場估計與預測:按最終用戶分類,2021 - 2032 年

  • 主要趨勢
  • 醫院
  • 婦產科診所
  • 診斷實驗室
  • 門診手術中心
  • 其他最終用戶

第 8 章:市場估計與預測:按地區,2021 - 2032

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 丹麥
    • 瑞典
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 中東和非洲其他地區

第 9 章:公司簡介

  • Abbott Laboratories
  • Allengers Medical
  • Alphabet Inc.
  • Caldera Medical
  • Carestream Health
  • Garmin Ltd.
  • GE Healthcare Technologies Inc.
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Mankind Pharma Limited
  • OMRON Corporation
  • Organon and Co.
  • Samsung Electronics co., Ltd.
  • The Cooper Companies, Inc.
簡介目錄
Product Code: 3191

The Global Women Health Devices Market was valued at approximately USD 129.9 billion in 2023 and is projected to grow at a CAGR of 9.2% from 2024 to 2032. Women's health devices include medical instruments, equipment, and tools designed for diagnosing, monitoring, and treating health conditions unique to women. These devices address the anatomical and physiological needs of women throughout various life stages, from adolescence to menopause and beyond. They cover reproductive health, gynecological care, and conditions like breast cancer, cervical cancer, osteoporosis, and pelvic floor disorders. The aging global population, particularly among women, is increasing urinary incontinence issues. This condition, often due to weakened pelvic floor muscles, affects about 25 million adults in the U.S., with 75-80% being women, and around 200 million worldwide.

The overall women health devices industry is classified based on the product, application, end use r, and region.

The women health devices market is divided into devices and consumables. The devices segment includes contraceptive devices, fertility monitoring tools, menstrual health products, breast and pelvic health devices, maternal health products, general health monitors, gynecological medical devices, and more. Forecasts suggest this segment will reach USD 211.4 billion by 2032. Several factors drive this growth: heightened awareness among women about their health needs, the emergence of specialized devices, technological advancements yielding efficient and user-friendly products, and a societal shift towards preventive healthcare.

The market is divided into areas like cancer, osteoporosis, infectious diseases, uterine fibroids, pregnancy, female sterilization, and menstrual disorders. The infectious diseases segment is set to grow at a CAGR of 7.9% during the analysis period. Infectious diseases affecting women, such as urinary tract infections (UTIs), sexually transmitted infections (STIs), and vaginal infections, are globally prevalent. For instance, the WHO reported in 2022 that twenty million women were HIV-positive, with 540,000 new cases and 23,000 related deaths.

In the U.S., the women health devices market is projected to reach USD 78.8 billion by 2032. Heightened awareness about women's health and preventive care drives the demand for specialized devices. Initiatives promoting regular screenings and early diagnoses, especially for breast cancer and osteoporosis, further fuel this growth. Other growth drivers include rising healthcare expenditures, supportive government initiatives, medical technology advancements, and the increasing prevalence of lifestyle-related diseases. Together, these factors enhance women's healthcare accessibility and quality, expanding the market.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry impact forces
    • 3.1.1 Growth drivers
      • 3.1.1.1 Increasing disease burden among women in developed countries
      • 3.1.1.2 Rising elderly female population worldwide
      • 3.1.1.3 Technological advancements in healthcare industry
      • 3.1.1.4 Increasing awareness regarding women health in developing countries
    • 3.1.2 Industry pitfalls and challenges
      • 3.1.2.1 High cost of devices and procedures
      • 3.1.2.2 Lack of awareness among women in underdeveloped economies
  • 3.2 Growth potential analysis
  • 3.3 Technology landscape
  • 3.4 Future market trends
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategic outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Devices
    • 5.2.1 Contraceptive devices
    • 5.2.2 Fertility monitoring devices
    • 5.2.3 Menstrual health products
    • 5.2.4 Breast health devices
    • 5.2.5 Pelvic health devices
    • 5.2.6 Maternal health products
    • 5.2.7 General health monitoring devices
    • 5.2.8 Medical devices for gynecological conditions
    • 5.2.9 Other devices
  • 5.3 Consumables

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Cancer
  • 6.3 Osteoporosis
  • 6.4 Infectious diseases
  • 6.5 Uterine fibroids
  • 6.6 Pregnancy
  • 6.7 Female sterilization
  • 6.8 Menstrual disorders
  • 6.9 Other applications

Chapter 7 Market Estimates and Forecast, By End-user, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Obstetrics and gynecology clinics
  • 7.4 Diagnostic laboratories
  • 7.5 Ambulatory surgical centers
  • 7.6 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Russia
    • 8.3.7 Denmark
    • 8.3.8 Sweden
    • 8.3.9 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Qatar
    • 8.6.5 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Abbott Laboratories
  • 9.2 Allengers Medical
  • 9.3 Alphabet Inc.
  • 9.4 Caldera Medical
  • 9.5 Carestream Health
  • 9.6 Garmin Ltd.
  • 9.7 GE Healthcare Technologies Inc.
  • 9.8 Hologic, Inc.
  • 9.9 Koninklijke Philips N.V.
  • 9.10 Mankind Pharma Limited
  • 9.11 OMRON Corporation
  • 9.12 Organon and Co.
  • 9.13 Samsung Electronics co., Ltd.
  • 9.14 The Cooper Companies, Inc.